Drug Safety :: PDUFA recommendations will strengthen drug review and drug safety
The U.S. Food and Drug Administration (FDA) recently submitted to Congress its final proposal for reauthorizing the Prescription Drug User Fee Act (PDUFA IV) after reviewing public comments.